32 /100
MEDIUM RISK
Score updated May 30, 2026

GLTO — Damora Therapeutics, Inc. Dilution Risk Tracker

Track GLTO dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track GLTO — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
95
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for GLTO.
🔔 Track GLTO — Get forecast alerts →

💹 Market Data

Market Cap$1.73B
Shares Outstanding60.24M
Float1.05M
Cash$568.89M
Debt$72.0K
Short InterestN/A

🏛 Institutional Holdings

18 institutional holders · 1.11M shares
#1 Ikarian Capital, LLC 285.7K shares
#2 FMR LLC 238.9K shares
#3 Jain Global LLC 120.6K shares
+ 15 more holders Sign up free to view →

📉 Short Interest

Short Interest169.3K
Days to Cover6.3
% of Float16.2%
FINRA data as of Jan 15, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2020
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track GLTO Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking GLTO — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for GLTO
📊 GLTO FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 GLTO Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.